- Home
- CVGI vs VERU Comparison
CVGI vs VERU Comparison
Compare CVGI & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGI
- VERU
- Stock Information
- Founded
- CVGI 2000
- VERU 1971
- Country
- CVGI United States
- VERU United States
- Employees
- CVGI N/A
- VERU N/A
- Industry
- CVGI Auto Parts:O.E.M.
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- CVGI Consumer Discretionary
- VERU Health Care
- Exchange
- CVGI Nasdaq
- VERU Nasdaq
- Market Cap
- CVGI 50.7M
- VERU 40.6M
- IPO Year
- CVGI 2004
- VERU 1990
- Fundamental
- Price
- CVGI $1.66
- VERU $2.37
- Analyst Decision
- CVGI
- VERU Strong Buy
- Analyst Count
- CVGI 0
- VERU 2
- Target Price
- CVGI N/A
- VERU $25.00
- AVG Volume (30 Days)
- CVGI 158.2K
- VERU 197.4K
- Earning Date
- CVGI 11-10-2025
- VERU 12-15-2025
- Dividend Yield
- CVGI N/A
- VERU N/A
- EPS Growth
- CVGI N/A
- VERU N/A
- EPS
- CVGI N/A
- VERU N/A
- Revenue
- CVGI $657,532,000.00
- VERU $16,886,419.00
- Revenue This Year
- CVGI N/A
- VERU N/A
- Revenue Next Year
- CVGI $6.79
- VERU N/A
- P/E Ratio
- CVGI N/A
- VERU N/A
- Revenue Growth
- CVGI N/A
- VERU 337.24
- 52 Week Low
- CVGI $0.81
- VERU $2.11
- 52 Week High
- CVGI $2.65
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- CVGI 56.70
- VERU 32.56
- Support Level
- CVGI $1.48
- VERU $2.11
- Resistance Level
- CVGI $1.64
- VERU $2.57
- Average True Range (ATR)
- CVGI 0.14
- VERU 0.19
- MACD
- CVGI 0.02
- VERU -0.00
- Stochastic Oscillator
- CVGI 97.44
- VERU 30.67
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.